TS

Toofan Singh

Active Director Director DIN 10103204
DIN 10103204 First appointment Apr 2023 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2023
Shareholding value •••• Premium profile

About Toofan Singh

Data last updated:

Toofan Singh is a Director at Eyechem Pharmaceuticals Private Limited (since 2023). The company operates in Pharma. Eyechem Pharmaceuticals Private Limited reported revenue of ₹8.4 Lakh (FY 2024).

DIN 10103204
Primary Designation Director
Industry Pharma
First Appointment 06 Apr 2023
Oldest Company Age 3 yrs
Largest company Eyechem Pharmaceuticals Private Limited · ₹8.4 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director06 Apr 20232023₹8.4 Lakh (FY 2024)Active

Board colleagues of Toofan Singh

NameDINCompanyDesignation
Lata Singh10103203Eyechem Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Eyechem Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Toofan Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Toofan Singh

Toofan Singh currently holds 1 directorship: Eyechem Pharmaceuticals Private Limited (Director, since 06 Apr 2023, revenue ₹8.4 Lakh (FY 2024)).

Toofan Singh was first appointed on 06 Apr 2023 as Director at Eyechem Pharmaceuticals Private Limited.

The current boards of Toofan Singh's companies include Lata Singh (Eyechem Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available